Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

ALS Untangled finds no evidence that PoNS slows ALS progression

Original source

PoNS DeviceALSUntangled · 29 April 2024 (opens in a new tab)

ALS Untangled reviewed the PoNS™ electrical stimulation device and found no clinical or preclinical evidence testing it in people with ALS. The device’s effects on ALS progression are unknown, and evidence from multiple sclerosis may not apply to ALS. ALS Untangled does not support using PoNS™ to slow, stop or reverse ALS progression.

Why this matters

People with ALS should not assume that PoNS™ can change the course of their disease. The device may be relatively safe, but its substantial cost and prescription-only status could limit access, and its effectiveness for ALS has not been established.

Limitations and context

This is an expert review, not a clinical trial of PoNS™ in ALS. The assessment is based on the lack of ALS-specific preclinical and clinical data; future research would be needed to determine whether the device has benefits or harms for people with ALS.

Summarised by Compass 9 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?